5th WSO-GAINS-ESO Early Career Investigators Workshop. Join us for this workshop aimed at connecting early career stroke investigators with each other, and also with experienced mentors from across the globe!
Deadline for submissions is August 15, 2025
Registration is now open for the 16th World Stroke Congress in Abu Dhabi. Join the WSO in shaping the future of stroke care!
ESOC 10th Anniversary Conference - May 2024! ESOC 2024 is taking place exclusively onsite in Basel, going back to the heart of an annual medical conference.
Please probe your networks and reach out to PIs who may need assistance with, or who are planning a stroke clinical trial and would like to present to our global network. Please send us the names and contact information of these PIs at your earliest convenience, but no later than 30-April, so we can plan our program. Contact Rose at beckmare@ucmail.uc.edu.
We would like to focus on clinical trials that are preferably multinational; investigator-initiated/conducted; phase 2b/3; with widely applicable interventions relevant to low- or middle-income countries as well; where some funding is already secured or the main funding body clearly defined. We are also happy to provide scientific input on trials that have yet to be funded but are still in the concept phase.
Virtual GAINS Clinical Trials Forum IV
Monday, January 24, 2022 from 8-10 am ET. A zoom invitation will follow.
We would like to focus on clinical trials that are preferably multinational; investigator-initiated/conducted; phase 2b/3; with widely applicable interventions relevant to low or middle income countries as well; where some funding is already secured or main funding body clearly defined. We are also happy to provide scientific input on trials that have yet to be funded but are still in the concept phase.
Call for Presenters!
We would like to focus on clinical trials that are preferably multinational; investigator-initiated/conducted; phase 2b/3; with widely applicable interventions relevant to low- or middle-income countries as well; where some funding is already secured or the main funding body clearly defined. We are also happy to provide scientific input on trials that have yet to be funded but are still in the concept phase.
